Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zevra Therapeutics

7.87
+0.08001.03%
Post-market: 7.870.00000.00%16:05 EDT
Volume:363.46K
Turnover:2.90M
Market Cap:430.33M
PE:-3.45
High:8.08
Open:7.82
Low:7.82
Close:7.79
Loading ...

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
13 hours ago

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
06 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
03 May

Zevra Therapeutics urges stockholders to vote for director nominees

TIPRANKS
·
21 Apr

Zevra Therapeutics Inc - Board Recommends Voting 'for' Wendy L. Dixon and Tamara a. Favorito

THOMSON REUTERS
·
21 Apr

Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders

GlobeNewswire
·
21 Apr

Zevra Therapeutics announces publication on arimoclomol

TIPRANKS
·
17 Apr

Zevra Announces Publication of Miplyffa® Mechanism of Action Manuscript in Molecular Genetics and Metabolism

THOMSON REUTERS
·
17 Apr

Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism

GlobeNewswire
·
17 Apr

BRIEF-Zevra Announces Closing Of Sale Of Rare Pediatric Disease Priority Review Voucher

Reuters
·
07 Apr

Zevra Therapeutics Nets $150 Million From US FDA Voucher Sale, Increases Cash Reserves

MT Newswires Live
·
07 Apr

Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

THOMSON REUTERS
·
07 Apr

Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

GlobeNewswire
·
07 Apr

Zevra Therapeutics Asks Shareholders to Reject Director Nominees by Activist Investor

MT Newswires Live
·
01 Apr

Zevra Therapeutics: Confirms Receipt of Two Director Nominees From Daniel J. Mangless

THOMSON REUTERS
·
01 Apr

Zevra Therapeutics Files Preliminary Proxy

THOMSON REUTERS
·
01 Apr

Zevra Therapeutics Files Preliminary Proxy

GlobeNewswire
·
01 Apr

Zevra Therapeutics management to meet with Cantor Fitzgerald

TIPRANKS
·
26 Mar

John Bode Bought 33% More Shares In Zevra Therapeutics

Simply Wall St.
·
23 Mar

Top Executive Makes Bold Move with Major Stock Purchase in Zevra Therapeutics!

TIPRANKS
·
22 Mar